AHSG and type 2 diabetes mellitus: In the current study, we find evidence that genetically predicted fetuin-A increases coronary artery disease risk in individuals with type 2 diabetes, but we do not find an association between genetically predicted fetuin-A and coronary artery disease in participants without type 2 diabetes.